Gabriel Morris
Director of Finance/CFO at IMMIX BIOPHARMA, INC.
Net worth: 1 M $ as of 29/04/2024
Gabriel Morris active positions
Companies | Position | Start | End |
---|---|---|---|
IMMIX BIOPHARMA, INC. | Director/Board Member | 28/02/2021 | - |
Director of Finance/CFO | 28/02/2021 | - | |
Investor Relations Contact | 28/02/2021 | - | |
Alwaysraise LLC | Corporate Officer/Principal | 31/12/2019 | - |
Nexcella, Inc.
Nexcella, Inc. BiotechnologyHealth Technology Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned. | President | - | - |
Career history of Gabriel Morris
Former positions of Gabriel Morris
Companies | Position | Start | End |
---|---|---|---|
Campbell & Co. LP
Campbell & Co. LP Investment ManagersFinance Campbell & Co. LP provides investments management services. It is a pioneer in absolute return investment management, specializing in systematic managed futures and equity market-neutral strategies. The company provides absolute return investment strategies and global diversification in a single investment. Campbell & Co was founded in 1972 and is located in Towson, MD. | Chief Operating Officer | - | 02/01/2021 |
ZAP Surgical Systems, Inc.
ZAP Surgical Systems, Inc. Internet Software/ServicesTechnology Services Zap Surgical Systems, Inc. operates as a gyroscopic radiosurgery platform. The company was founded by John R. Adler and is headquartered in San Carlos, CA. | Director of Finance/CFO | 31/12/2018 | 31/12/2019 |
Training of Gabriel Morris
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Statistics
International
United States | 7 |
Operational
Director of Finance/CFO | 2 |
Director/Board Member | 1 |
Investor Relations Contact | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
IMMIX BIOPHARMA, INC. | Health Technology |
Private companies | 4 |
---|---|
Alwaysraise LLC | |
ZAP Surgical Systems, Inc.
ZAP Surgical Systems, Inc. Internet Software/ServicesTechnology Services Zap Surgical Systems, Inc. operates as a gyroscopic radiosurgery platform. The company was founded by John R. Adler and is headquartered in San Carlos, CA. | Technology Services |
Campbell & Co. LP
Campbell & Co. LP Investment ManagersFinance Campbell & Co. LP provides investments management services. It is a pioneer in absolute return investment management, specializing in systematic managed futures and equity market-neutral strategies. The company provides absolute return investment strategies and global diversification in a single investment. Campbell & Co was founded in 1972 and is located in Towson, MD. | Finance |
Nexcella, Inc.
Nexcella, Inc. BiotechnologyHealth Technology Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned. | Health Technology |
- Stock Market
- Insiders
- Gabriel Morris
- Experience